Gonadotrophins in the treatment anovulatory women
US7695721B1 · kind B1 · utility
2Cited by
5References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 5, 2000 |
| Grant date | Apr 13, 2010 |
| Priority date | — |
| Expiry date | May 5, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P15/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of gonadotrophins in the induction of folliculogenesis in anovulatory women. In particular, if relates to the use of LH (or an equivalent dosage of hCG) in the production of a medicament for inducing folliculogenesis in anovulatory women at a specified daily doses. In certain embodiments. LH may be used in conjunction with FSH.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.